Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We compared 3-year achievement of an American Diabetes Association composite treatment goal (HbA1c <7.0%, LDL cholesterol <100 mg/dL, and systolic blood pressure <130 mmHg) after 2 years of intensive lifestyle-medical management intervention, with and without Roux-en-Y gastric bypass, with one additional year of usual care. RESEARCH DESIGN AND METHODS: A total of 120 adult participants, with BMI 30.0–39.9 kg/m2 and HbA1c ≥8.0%, were randomized 1:1 to two treatment arms at three clinical sites in the U.S. and one in Taiwan. All patients received the lifestyle-medical management intervention for 24 months; half were randomized to also receive gastric bypass. RESULTS: At 36 months, the triple end point goal was met in 9% of lifestyle-medical management patients and 28% of gastric bypass patients (P = 0.01): 10% and 19% lower than at 12 months. Mean (SD) HbA1c values at 3 years were 8.6% (3.5) and 6.7% (2.0) (P < 0.001). No lifestyle-medical management patient had remission of diabetes at 36 months, whereas 17% of gastric bypass patients had full remission and 19% had partial remission. Lifestyle-medical management patients used more medications than gastric bypass patients: mean (SD) 3.8 (3.3) vs. 1.8 (2.4). Percent weight loss was mean (SD) 6.3% (16.1) in lifestyle-medical management vs. 21.0% (14.5) in gastric bypass (P < 0.001). Over 3 years, 24 serious or clinically significant adverse events were observed in lifestyle-medical management vs. 51 with gastric bypass. CONCLUSIONS: Gastric bypass is more effective than lifestyle-medical management intervention in achieving diabetes treatment goals, mainly by improved glycemic control. However, the effect of surgery diminishes with time and is associated with more adverse events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ikramuddin et al. [31] and Schauer et al. [32] demonstrated superior diabetes improvement and weight loss following MBS in randomized controlled trials that include the subset of patients with BMI <35 kg/m2.”
Citations
Cites
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901 · cited 3×
“Therewasan increase inHDL inbothgroups by 36 months, more so in gastric bypass, consistent with other reports (11).”
BackgroundResultBariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah, S. H. (2004) · JAMA · doi:10.1001/jama.291.3.335 · Cited by 1,357 · cited 1×
“Triple end point 0 (0) 1 (2) 13 (22) 8 (14) 9.”
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054 · cited 3×
“Post hoc analysis from a long-term prospective study showed that bariatric surgery improved glycemic control but had less benefit on blood pressure and dyslipidemia (12).”
BackgroundHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003 · cited 5×
“HDL cholesterol (mg/dL) 42 (16) 46 (18) 51 (20) 53 (19) 7.”
BackgroundInfluential
Cited by
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., De Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.013 · Cited by 985
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., de Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-022-06332-1 · Cited by 768
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Mechanick, J. I., Apovian, C., Brethauer, S., Timothy Garvey, W., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 389
Ikramuddin, S., Korner, J., Lee, W.-J., Thomas, A. J., Connett, J. E., Bantle, J. P., Leslie, D. B., Wang, Q., Inabnet, W. B., Jeffery, R. W., et al. (2018) · JAMA · doi:10.1001/jama.2017.20813 · Cited by 291
“4 2 (0 to 11) 22 (11 to 37) 20 (6-34) 10.”
Self-citationAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s008 · Cited by 244
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s008 · Cited by 244
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s008 · Cited by 236
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s008 · Cited by 213
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s008 · Cited by 149
“Available data suggest an erosion of diabetes remissionover time (63): 35%–50%ormore of patients who initially achieve remission of diabetes eventually experience recurrence.”
BackgroundAmerican Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s008 · Cited by 158
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s008 · Cited by 148
le Roux, C. W., & Heneghan, H. M. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.011 · Cited by 139
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Tahrani, A. A., & Morton, J. (2022) · Obesity · doi:10.1002/oby.23371 · Cited by 125
Courcoulas, A., Coley, R. Y., Clark, J. M., McBride, C. L., Cirelli, E., McTigue, K., Arterburn, D., Coleman, K. J., Wellman, R., Anau, J., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2019.5470 · Cited by 119
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s007 · Cited by 117
“Available data suggest an erosion of diabetes remission over time (51): 35– 50% or more of patients who initially achieve remission of diabetes eventually experience recurrence.”
BackgroundHerbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017
Liu, Y., Sun, M., Yao, H., Liu, Y., & Gao, R. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8943059 · Cited by 131
ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m2)
Aminian, A., Chang, J., Brethauer, S. A., & Kim, J. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.025 · Cited by 106
Ding, L., Fan, Y., Li, H., Zhang, Y., Qi, D., Tang, S., Cui, J., He, Q., Zhuo, C., & Liu, M. R. (2020) · Obesity Reviews · doi:10.1111/obr.13030 · Cited by 118
Khorgami, Z., Shoar, S., Saber, A. A., Howard, C. A., Danaei, G., & Sclabas, G. M. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3552-x · Cited by 100
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s008 · Cited by 165
Park, C. H., Nam, S., Choi, H. S., Kim, K. O., Kim, D. H., Kim, J., Sohn, W., Yoon, J. H., Jung, S. H., Hyun, Y. S., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03831-6 · Cited by 94
Advances in the management of type 2 diabetes in adults
Galindo, R. J., Trujillo, J. M., Wang, C. C. L., & McCoy, R. G. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000372 · Cited by 109
Recent advancements in bariatric/metabolic surgery
Lee, W., & Almalki, O. M. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12030 · Cited by 88
Self-citationSurgical management of obesity
Nudel, J., & Sanchez, V. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.002 · Cited by 75
Chen, J., Hsu, N., Lee, W., Chen, S.-C., Ser, K., & Lee, Y.-C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.027 · Cited by 60
Self-citationAppetite-Suppressing and Satiety-Increasing Bioactive Phytochemicals: A Systematic Review
Stuby, J., Gravestock, I., Wolfram, E., Pichierri, G., Steurer, J., & Burgstaller, J. M. (2019) · Nutrients · doi:10.3390/nu11092238 · Cited by 59
“, infection, deep vein thrombosis, acute pancreatitis, hernia [13,14]), as well as the fact that the majority of obese patients do not fulfill the criteria for those interventions, are reasons why there is an urgent need for alternative treatments [7,10,11,15].”
BackgroundHauge, J. W., Borgeraas, H., Birkeland, K. I., Johnson, L. K., Hertel, J. K., Hagen, M. C., Gulseth, H. L., Lindberg, M., Lorentzen, J., Seip, B., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00396-6 · Cited by 53
Toulabi, T., Yarahmadi, M., Goudarzi, F., Ebrahimzadeh, F., Momenizadeh, A., & Yarahmadi, S. (2021) · EXPLORE · doi:10.1016/j.explore.2021.05.003 · Cited by 53
Bischoff, S. C., & Schweinlin, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.04.013 · Cited by 56
Metabolic and Bariatric Surgery for Obesity
Vidal, J., Corcelles, R., Jiménez, A., Flores, L., & Lacy, A. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.051 · Cited by 45
Network meta‐analysis of the relative efficacy of bariatric surgeries for diabetes remission
Kodama, S., Fujihara, K., Horikawa, C., Harada, M., Ishiguro, H., Kaneko, M., Furukawa, K., Matsubayashi, Y., Matsunaga, S., Shimano, H., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12751 · Cited by 42
“Six RCTs (19,21,25,26,28,36) could only provide limited ascertainment of diabetes status because FPG was not included in the criteria for diabetes remission.”
BackgroundReconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass
Isaman, D. J. M., Rothberg, A. E., & Herman, W. H. (2016) · Diabetes Care · doi:10.2337/dc16-0954 · Cited by 33
“15 percentage points higher when metformin was allowed (23).”
BackgroundDietary macro- and micro-nutrients intake adequacy at 6th and 12th month post-bariatric surgery
Ziadlou, M., Hosseini‐Esfahani, F., Khosravi, H. M., Hosseinpanah, F., Barzin, M., Khalaj, A., & Valizadeh, M. (2020) · BMC Surgery · doi:10.1186/s12893-020-00880-y · Cited by 33
Metabolic Surgery and Diabesity: a Systematic Review
Khoury, L. E., Chouillard, E. K., Chahine, E., Saikaly, E., Debs, T., & Kassir, R. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3252-6 · Cited by 33
Outcomes After Metabolic Surgery in Asians—a Meta-analysis
Yeo, D. X. W., Yeo, C., Low, T. Y., Ahmed, S., Phua, S. S. H., Oo, A. M., Rao, J., Koura, A. N., Venkataraman, K., & Sanghvi, K. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3484-5 · Cited by 27
Effects of culinary herbs and spices on obesity: A systematic literature review of clinical trials
Deekshith, C., Jois, M., Radcliffe, J., & Thomas, J. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104449 · Cited by 28
Ilyas, S., Al-Refai, R., Maharjan, R., Bustamante, L. D., Ghattas, K. N., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.9973 · Cited by 38
Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes
Jiang, C., Cifu, A. S., & Sam, S. (2022) · JAMA · doi:10.1001/jama.2022.10338 · Cited by 25
Bariatric Surgery: A Perspective for Primary Care
Kizy, S., Jahansouz, C., Wirth, K. M., Ikramuddin, S., & Leslie, D. B. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0034 · Cited by 28
“Gut hormone PYY(3-36) physiologically inhibits food intake.”
InfluentialSelf-citationFeng, W., Yin, T., Chu, X., Shan, X., Jiang, C., Wang, Y., Qian, Y., Zhu, D., Sun, X., & Bi, Y. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3138 · Cited by 24
“Weight loss has been shown to improve glycaemic control.(14) For obese patients with T2DM in the RYGB group, sustained improvement in glycaemic levels may be a benefit from the continuous weight loss after surgery.”
BackgroundResultInfluentialCui, B., Wang, G., Li, P., Li, W., Zhu, L., & Zhu, S. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.03.001 · Cited by 23
Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia
Lee, W., & Aung, L. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.6.433 · Cited by 21
“(2016) [3] 2008–2011 Taiwan and USA T2DM with BMI 30–35 kg/m(2) 2 Medical (16) RYGB (14) DM remission 0% vs.”
BackgroundSelf-citationBilleter, A. T., Herrera, J. R. D. L. G., Scheurlen, K. M., Nickel, F., Billmann, F. G., & Müller-Stich, B. P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0009 · Cited by 20
Examining the evidence for weight management in individuals with type 2 diabetes
Garvey, W. T., Umpierrez, G. E., Dunn, J. P., Kwan, A. Y. M., Varnado, O. J., Konig, M., & Levine, J. A. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14764 · Cited by 18
Arumugam, G., Nagarathna, R., Majumdar, V., Singh, M., Srinivasalu, R., Sanjival, R., Ram, V. S., & Nagendra, H. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-63133-1 · Cited by 17
Kim, J. H., Pyo, J., Cho, W. J., & Kim, S. Y. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04257-w · Cited by 15
“Mean Difference of Fasting Plasma Glucose (mg/dL) After Bariatric Surgery and Medical Treatment In Table 5, patients who had undergone bariatric surgery showed a greater reduction in FPG levels than those who had undergone medical treatment.”
InfluentialPilla, S. J., Maruthur, N. M., Schweitzer, M., Magnuson, T. H., Potter, J. J., Clark, J. M., & Lee, C. J. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2804-5 · Cited by 15
“undergoing surgery [25]; this threshold would have correctly classified all participants in our study.”
Halpern, B., & Mancini, M. C. (2019) · Obesity Reviews · doi:10.1111/obr.12837 · Cited by 14
“The diabetes remission rate was 42% after 2 years and 36% after 3 years in the RYGB group (60 patients).(99,100) However, their study had a less favourable”
BackgroundResultPujol‐Rafols, J., Carmona‐Maurici, J., Felsenreich, D. M., Shikora, S. A., Prager, G., Lorenzo, N. D., Luca, M. D., Uyanik, O., Mazzarella, M., D’Arco, S., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07142-3 · Cited by 14
Li, D., Zou, H., Yin, P., Li, W., He, J., Wang, S., Huang, L., Shao, S., Chen, Y., Yang, Y., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14217 · Cited by 11
Lafarge, J.-C., Aron‐Wisnewsky, J., Pattou, F. N., Cucherat, M., Blondet, E., Lascols, S., Guludec, D. L., David, D.-J., & Carbonneil, C. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101495 · Cited by 12
Liakopoulos, V., Franzén, S., Svensson, J., Zethelius, B., Ottosson, J., Näslund, I., Guðbjörnsdóttir, S., & Eliasson, B. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000386 · Cited by 11
Huang, Y., Lin, Y., Lee, W., Hur, K. Y., Kasama, K., Cheng, A. K. S., Lee, M., Wong, S. K., Soong, T., Lee, K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14279 · Cited by 11
Self-citationMirghani, H. O., Alamrani, S. A. S., Alkonani, A. A., & Madshush, A. M. A. A. (2023) · Cureus · doi:10.7759/cureus.49122 · Cited by 17
“Ikramuddin et al. (2016) [17] investigated the outcomes of RYGB and found a mean weight loss of 21.0% (SD 14.5) and a significant decrease in HbA1c values at three years.”
BackgroundInfluentialCOHEN, R. V., Azevedo, M. A., le Roux, C. W., Caldeon, L. P., Luque, A., Fayad, D. A., & Petry, T. B. Z. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07535-4 · Cited by 11
Metabolic surgery in South Africa: an initial academic hospital experience
Lübbe, J., Webner, A., Potgieter, A., Odendaal, W., Cooper, C., & Lambrechts, A. (2019) · South African Journal of Surgery · doi:10.17159/2078-5151/2019/v57n2a2804 · Cited by 9
Chen, M., Surbhi, S., & Bailey, J. E. (2021) · American Journal of Health Promotion · doi:10.1177/08901171211024426 · Cited by 8
Grong, E., Nord, C., Arbo, I. B., Eriksson, M., Kulseng, B. E., Ahlgren, U., & Mårvik, R. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0793-9 · Cited by 8
Rossi, I. R., Omotosho, P. A., Poirier, J., Spagnoli, A., & Torquati, A. (2020) · Surgery · doi:10.1016/j.surg.2020.09.039 · Cited by 9
Chen, H., Guo, X., Long, T., & Li, M. (2026) · Obesity Surgery · doi:10.1007/s11695-025-08415-1 · Cited by 7
Ling, J., Tang, H., Meng, H., Wu, L., Zhu, L., & Zhu, S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01811-9 · Cited by 6
Yang, X., Zhong, Q., Li, L., Ya, C., Tang, C., Liu, T., Luo, S., Xiong, J., & Wang, L. (2023) · Reproductive Health · doi:10.1186/s12978-023-01728-3 · Cited by 8
“To address the issue of missing data and ensure the integrity of our analysis, we employed a multiple imputation technique [26].”
Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes
Justinussen, T., Madsbad, S., Holst, J. J., & Bojsen-Møller, K. N. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1628639 · Cited by 7
“1 and 2 years following surgery 25–60% of RYGB operated subjects achieved complete remission [7,14,21,22], 17–35% at 3 years [8,23] and 5% and 22%, respectively, at 5 years in the”
BackgroundEconomics and Policy in Bariatric Surgery
Hoerger, T. J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1148-z · Cited by 6
Consenso ALAD. Tratamiento del paciente con diabetes mellitus tipo 2 y obesidad
BRAJKOVICH, I. E., Aschner, P. J., Taboada, L. B., Camperos, P., Gómez‐Pérez, R., Aure, G., Velásquez, M. E., Halpern, B., Jiménez, M. C. H., & Fuentes, O. (2019) · Alad · doi:10.24875/alad.19000369 · Cited by 11
Pajecki, D., Dantas, A. C. B., Santo, M. A., & Tess, B. H. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06516-3 · Cited by 4
“There was no statistically relevant correlation between EOSS severity and BMI, demonstrating the greater sensitivity of the staging method in identifying the most severe cases.”
BackgroundInfluentialGul, D., Khan, A. W., Butt, M. A., Suheb, M. K., Sartaj, S., Chabria, S., Bint-e-Hina, R., Shaukat, M., Ali, Z., Bhurchandi, S. K., et al. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01526-z · Cited by 4
“…pooled analysis of four studies [13, 25, 27, 31]; 2-year-RR 8.95, 95% CI 1.71 46.71, p-value 0.009, I 2 92%, pooled analysis of five studies [17, 19, 22, 27, 29]; 3-year-RR 18.18, 95% CI 7.57 43.62, p-value < 0.00001, I 2 0%, pooled analysis of six studies [14, 16, 21, 26, 27, 30]; 5-year-RR…”
InfluentialHuang, M., Xie, W., Kang, L., Luo, D., He, Q., & Yang, X. (2025) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.70001 · Cited by 6
“To address the issue of missing data and ensure the integrity of our analysis, we employed a multiple imputation technique for these variables 20 .”
Wiggins, T., Jamel, S., Hakky, S., Ahmed, A., Markar, S. R., & Hanna, G. B. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.08.020 · Cited by 6
Metabolic and bariatric surgery: Surgical options and outcomes
Lübbe, J., Smit, J. G. M., Koto, Z., Conradie-Smit, M., & May, W. (2025) · South African Medical Journal · doi:10.7196/samj.2025.v115i9b.3683 · Cited by 3
“[53] The place of MBS in the management of T2DM was ultimately recognised by the International Diabetes Federation (IDF) in 2011 [58] and by the Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) in 2017, [59] both stating that surgery should be considered as an alternative…”
Study design and recruitment for a prospective controlled study of diabesity: Taiwan Diabesity Study
Lee, W., Chang, Y., Almalki, O. M., Chao, S., Lu, C. H., Chen, C., Huang, Y., Lee, Y.-C., & Hsu, C. (2018) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2018.02.007 · Cited by 3
Self-citationIsmail, M., Nagaraj, D., Rajagopal, M., Ansari, H., Iyyankutty, K., Nair, M., Hegde, A., & Rekha, P. D. (2020) · Journal of Minimal Access Surgery · doi:10.4103/jmas.jmas_108_19 · Cited by 4
Halpern, B., Cercato, C., & Mancini, M. C. (2017) · Diabetes Care · doi:10.2337/dc16-1482 · Cited by 3
“was a clear relationship between weight loss and glycemic control (7).”
BackgroundHerbal Treatments for Obesity: A Review
Gasmi, A., Noor, S., Mujawdiya, P. K., Akram, M., Manzoor, A., & Bjørklund, G. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673287491240315055726 · Cited by 4
Comparative Surgical Outcomes in Bariatric Surgery
Alvarez, R., & Telem, D. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-71282-6_29 · Cited by 2
Gautam, P., Pattanshetti, S., & Rayate, N. V. (2020) · Indian Journal of Surgery · doi:10.1007/s12262-020-02657-2 · Cited by 2
The Case for Bariatric Surgery in Patients with Class 1 Obesity
Scott, A. W., Leslie, D. B., Ikramuddin, S., Dutta, N., Amateau, S. K., & Wise, E. S. (2023) · Current Surgery Reports · doi:10.1007/s40137-023-00355-y · Cited by 2
“[49] RCT RYGB vs MM 120 3 Years TBWL: 21.”
BackgroundSelf-citationCheng, J., Yu, H., Gu, Y., Ma, C., Li, C., Pan, Z., & Yuan, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70152 · Cited by 3
“7 However, available data suggest an erosion of diabetes remission over time 8 ; 35 – 50% of individuals eventually experience recurrence.”
Weck, M. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-119075 · Cited by 1
“Die Autoren dieser Studie [12] haben einen etwas anderen Ansatz gewählt als die bisher zitierten Studien.”
BackgroundImpact of Metabolic Surgery on Type-2 Diabetes Remission
Baiocchi, C. D. A. F., & de Sá, D. A. R. (2020) · Current Diabetes Reviews · doi:10.2174/1573399817999201214224920 · Cited by 2
Nutritional and Herbal Supplements for Weight Loss Management: A Review
Nannar, A. R., Shendge, R. S., & Salunkhe, K. S. (2023) · Current Nutrition & Food Science · doi:10.2174/1573401319666230725105537 · Cited by 3
Greenway, M., Domjancic, M., Liu, Y., Benzaquen, A., Racey, M., Jack, S. M., Sherifali, D., & Whitmore, C. (2025) · Obesity Reviews · doi:10.1111/obr.13980 · Cited by 1
Billeter, A. T., & Müller-Stich, B. P. (2019) · Der Chirurg · doi:10.1007/s00104-018-0786-z · Cited by 2
Lee, C. J., & Cheskin, L. J. (2017) · Annals of Internal Medicine · doi:10.7326/acpjc-2017-166-10-057 · Cited by 1
Mexican-Born Immigrant Decision-Making About Self-Management of Type 2 Diabetes
Hart-Kepler, V. (2017) · Digital USD (University of San Diego) · doi:10.22371/07.2017.009 · Cited by 2
“134 Contributing influences, persons and conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171 The family’s influence. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144 Health care provider influence . . . . . . . . . . . . . . . . . . . . . .…”
BackgroundInfluentialThe Role of Bariatric Surgery in Obese Patients with Diabetes: Primary or Rescue Therapy?
Gandikota, P., & Laferrère, B. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch14
Is Type 2 Diabetes a Surgical Disease?
Yeung, K. T. D., & Ahmed, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-93545-4_37
Can Bariatric Surgery Improve the Microvascular Complications of Type 2 Diabetes?
Shakerdi, L. A., le Roux, C. W., & Docherty, N. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-28803-7_50
Wang, X., Chen, C., Zheng, B., Yang, X., Zhang, X., & Yang, C. (2020) · Medicine · doi:10.1097/md.0000000000022755
Phytochemicals for Controlling Obesity-Related Cancers
Roy, M. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.04.000600 · Cited by 1
“acute pancreatitis, deep vein thrombosis, hernia and infections [70,71].”
BackgroundThe Role of Bariatric Surgery in Obese Patients with Diabetes
Gandikota, P., & Laferrère, B. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch18
Chirurgie bariatrique et diabète de type 2 : effets permanents ou temporaires ?
A, F. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30174-2
Lakdawala, M. A., & Bhasker, A. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-93545-4_7
Surgical Management for Diabetes Remission
Hurtado, A. M. D., & Collazo–Clavell, M. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_11
Current Approach of Diabetes Mellitus in Obese Patients
Karaburgu, S. (2023) · doi:10.69860/nobel.9786053359111.8
Bariatric Surgery Indications in the 2020s
Hill, C. E., Shikora, S. A., & Kothari, S. N. (2024) · Springer eBooks · doi:10.1007/978-3-031-72309-4_4
Rives‐Lange, C. (2023) · theses.fr (ABES) · doi:10.70675/4c790431zdbc6z4070z82cdz5ae265ebd90e
Demirel, T., Süt, N., & Ugale, S. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114027
Metadata
- Authors
- Ikramuddin, S., Korner, J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Wang, Q., Jeffery, R. W., Chong, K., Chuang, L.-M., Jensen, M. D., Vella, A., Ahmed, L., Belani, K., Olofson, A. E., Bainbridge, H. A., & Billington, C. J.
- Affiliations
- University of Minnesota (US)
- Division of Endocrinology, Department of Medicine, Columbia University Medical Center, New York, NY
- National Taiwan University Hospital (TW)
- Mount Sinai Hospital (US)
- Min Sheng General Hospital (TW)
- Mayo Clinic (US)
- Harlem Hospital Center (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Ikramuddin, Sayeed
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-06-16
- Volume
- 39
- Issue
- 9
- Pages
- 1510-1518
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5001141
- OpenAlex
- W2429202482
- Cited by
- 99
- References
- 28
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 8 · 2021: 7 · 2020: 17 · 2019: 13 · 2018: 14 · 2017: 12 · 2016: 3
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Covidien
- National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK-050456)
- National Center for Advancing Translational Sciences (UL1 TR000040, UL1 RR024156)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- Roux-en-Y gastric bypass, type 2 diabetes, obesity, lifestyle intervention, medical management, glycemic control, HbA1c, diabetes remission, weight loss, adverse events, bariatric surgery, treatment goals
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Combined Modality Therapy, Diabetes Mellitus, Type 2, Female, Goals, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Life Style, Cholesterol, LDL, Male, Middle Aged, Obesity, Remission Induction, Taiwan, Time Factors, United States, Gastric Bypass, Weight Loss, Treatment Outcome, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.